Researchers Uncover Genetic Key For Improved Blood-Thinning Therapy For African-American Patients

Researchers have discovered a way to make a blood thinner safer for about 40 percent of African-Americans taking the drug by linking a common gene variation to the dose. These findings, published June 4 EDT in The Lancet, are the latest results from ongoing collaborative work by 42 researchers from 17 institutions in the International Warfarin Pharmacogenetics Consortium led by University of Florida Health researcher Julie A. Johnson, a distinguished professor of pharmacy and medicine and director of the UF Center for Pharmacogenomics...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Blood / Hematology Source Type: news